Douglas P. Millay

4.8k citations

53 papers · 3.4k indexed · 1 hit paper · h-index 30

Molecular Biology top 2%
Physiology top 5%
Cell Biology top 5%
Cardiology and Cardiovascular Medicine top 5%
Genetics top 2%

Co-authors: Jeffery D. Molkentin Eric N. Olson Michael J. Petrany Michelle A. Sargent Rhonda Bassel‐Duby Qingnian Goh Lillian B. Sutherland Dilani G. Gamage
Topics: Muscle Physiology and Disorders (43 papers)RNA Research and Splicing (10 papers)Adipose Tissue and Metabolism (9 papers)
Cited by: Aging Molecular Biology Genetics
Journals: Nature Cell Proceedings of the National Academy of Sciences
Partner nations: United States Israel Norway

In The Last Decade

Douglas P. Millay

50 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Myomaker is a membrane activator of myoblast fusion and muscle formation

2013 394 citations Douglas P. Millay, Lillian B. Sutherland et al. profile →

Peers

Countries citing papers authored by Douglas P. Millay

Since Specialization

Citations

This map shows the geographic impact of Douglas P. Millay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas P. Millay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas P. Millay more than expected).

Fields of papers citing papers by Douglas P. Millay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas P. Millay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas P. Millay. The network helps show where Douglas P. Millay may publish in the future.

Co-authorship network of co-authors of Douglas P. Millay

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas P. Millay. A scholar is included among the top collaborators of Douglas P. Millay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas P. Millay. Douglas P. Millay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Localized Prox1 Regulates Aortic Valve Endothelial Cell Diversity and Extracellular Matrix Stratification in Mice 2023 ·Arteriosclerosis Thrombosis and Vascular Biology ·Anna O’Donnell,(unknown),(unknown),(unknown),Christina M. Alfieri,Casey O. Swoboda,Douglas P. Millay,Aaron M. Zorn,Katherine E. Yutzey	6
2	Comparing the epigenetic landscape in myonuclei purified with a PCM1 antibody from a fast/glycolytic and a slow/oxidative muscle 2021 ·PLoS Genetics ·(unknown),(unknown),Einar Eftestøl,Johannes Landskron,Chengyi Sun,(unknown),Diana Domańska,Douglas P. Millay,Leonardo A. Meza‐Zepeda,Kristian Gundersen	15
3	FOXF1 is required for the oncogenic properties of PAX3-FOXO1 in rhabdomyosarcoma 2021 ·Oncogene ·David Milewski,Samriddhi Shukla,Berkley E. Gryder,Arun Pradhan,(unknown),Parvathi Sudha,(unknown),(unknown),Yan Xu,Artem Barski,Sara Szabo,Brian Turpin,Joseph G. Pressey,Douglas P. Millay,Javed Khan,Vladimir V. Kalinichenko,Tanya V. Kalin	22
4	Myomerger promotes fusion pore by elastic coupling between proximal membrane leaflets and hemifusion diaphragm 2021 ·Nature Communications ·Gonen Golani,Evgenia Leikina,Kamran Melikov,Jarred M. Whitlock,Dilani G. Gamage,(unknown),Douglas P. Millay,Michael M. Kozlov,Leonid Chernomordik	38
5	ERK1/2 inhibition promotes robust myotube growth via CaMKII activation resulting in myoblast-to-myotube fusion 2021 ·Developmental Cell ·Tamar Eigler,(unknown),(unknown),(unknown),(unknown),(unknown),Assaf Zaritsky,Avraham Shakked,Kfir Baruch Umansky,Eyal D. Schejter,Douglas P. Millay,Eldad Tzahor,Ori Avinoam	56
6	TGFβ signaling curbs cell fusion and muscle regeneration 2021 ·Nature Communications ·(unknown),(unknown),Majid Ebrahimi,(unknown),Dilani G. Gamage,Cécile Peccate,Lorenzo Giordani,Douglas P. Millay,Penney M. Gilbert,Bruno Cadot,Fabien Le Grand	81
7	DOCK3 is a dosage-sensitive regulator of skeletal muscle and Duchenne muscular dystrophy-associated pathologies 2020 ·Human Molecular Genetics ·(unknown),Yimin Wang,Adrienne Samani,(unknown),Michael A. Lopez,Shawn R. Gilbert,Lara Ianov,David K. Crossman,Louis J. Dell’Italia,Douglas P. Millay,Thomas van Groen,Ganesh V. Halade,Matthew S. Alexander	9
8	Single-nucleus RNA-seq identifies transcriptional heterogeneity in multinucleated skeletal myofibers 2020 ·Nature Communications ·Michael J. Petrany,Casey O. Swoboda,Chengyi Sun,Kashish Chetal,Xiaoting Chen,Matthew T. Weirauch,Nathan Salomonis,Douglas P. Millay	212
9	Myonuclear content regulates cell size with similar scaling properties in mice and humans 2020 ·Nature Communications ·Kenth‐Arne Hansson,Einar Eftestøl,Jo C. Bruusgaard,(unknown),A. Cramer,Anders Malthe‐Sørenssen,Douglas P. Millay,Kristian Gundersen	59
10	Myocyte-derived Myomaker expression is required for regenerative fusion but exacerbates membrane instability in dystrophic myofibers 2020 ·JCI Insight ·Michael J. Petrany,Taejeong Song,Sakthivel Sadayappan,Douglas P. Millay	28
11	Myomaker and Myomerger Work Independently to Control Distinct Steps of Membrane Remodeling during Myoblast Fusion 2019 ·Biophysical Journal ·Evgenia Leikina,Dilani G. Gamage,Vikram Prasad,Leonid Chernomordik,Douglas P. Millay	1
12	Myoblast fusion confusion: the resolution begins 2018 ·Skeletal Muscle ·Srihari C. Sampath,Srinath C. Sampath,Douglas P. Millay	93
13	Exercise-Induced Skeletal Muscle Adaptations Alter the Activity of Adipose Progenitor Cells 2016 ·PLoS ONE ·Daniel Zeve,Douglas P. Millay,Jin Ho Seo,Jonathan M. Graff	11
14	Myomaker is essential for muscle regeneration 2014 ·Genes & Development ·Douglas P. Millay,Lillian B. Sutherland,Rhonda Bassel‐Duby,Eric N. Olson	136
15	Debio-025 is more effective than prednisone in reducing muscular pathology in mdx mice 2010 ·Neuromuscular Disorders ·(unknown),Douglas P. Millay,Grégoire Vuagniaux,Jeffery D. Molkentin	54
16	Magnetic resonance imaging assessment of cardiac dysfunction in δ-sarcoglycan null mice 2010 ·Neuromuscular Disorders ·Janaka Wansapura,Douglas P. Millay,R. Scott Dunn,Jeffery D. Molkentin,D. Woodrow Benson	10
17	Genetic Manipulation of Dysferlin Expression in Skeletal Muscle 2009 ·American Journal Of Pathology ·Douglas P. Millay,Marjorie Maillet,Joseph A. Roche,Michelle A. Sargent,Elizabeth M. McNally,Robert J. Bloch,Jeffery D. Molkentin	51
18	Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy 2008 ·Nature Medicine ·Douglas P. Millay,Michelle A. Sargent,Hanna Osińska,Christopher Baines,Elisabeth R. Barton,Grégoire Vuagniaux,H. Lee Sweeney,Jeffrey Robbins,Jeffery D. Molkentin	290
19	Genetic Disruption of Calcineurin Improves Skeletal Muscle Pathology and Cardiac Disease in a Mouse Model of Limb-Girdle Muscular Dystrophy 2007 ·Journal of Biological Chemistry ·Stephanie A. Parsons,Douglas P. Millay,Michelle A. Sargent,Francisco J. Naya,Elizabeth M. McNally,H. Lee Sweeney,Jeffery D. Molkentin	33
20	Age-Dependent Effect of Myostatin Blockade on Disease Severity in a Murine Model of Limb-Girdle Muscular Dystrophy 2006 ·American Journal Of Pathology ·Stephanie A. Parsons,Douglas P. Millay,Michelle A. Sargent,Elizabeth M. McNally,Jeffery D. Molkentin	80

About Douglas P. Millay

Douglas P. Millay is a scholar working on Aging, Molecular Biology and Rehabilitation, having authored 53 papers that have together received 3.4k indexed citations. Recurring topics across this work include Muscle Physiology and Disorders (43 papers), RNA Research and Splicing (10 papers) and Adipose Tissue and Metabolism (9 papers). The work is most often cited by research in Aging (108 citations), Molecular Biology (2.9k citations) and Genetics (375 citations). Douglas P. Millay has collaborated with scholars based in United States, Israel and Norway. Frequent co-authors include Jeffery D. Molkentin, Eric N. Olson, Michael J. Petrany, Michelle A. Sargent, Rhonda Bassel‐Duby, Qingnian Goh, Lillian B. Sutherland, Dilani G. Gamage, Vikram Prasad and Svetlana Bezprozvannaya. Their work appears in journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact